|
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Αρχειοθήκη ιστολογίου
-
►
2023
(272)
- ► Φεβρουαρίου (141)
- ► Ιανουαρίου (131)
-
►
2022
(2066)
- ► Δεκεμβρίου (80)
- ► Σεπτεμβρίου (170)
- ► Φεβρουαρίου (190)
- ► Ιανουαρίου (203)
-
▼
2021
(7399)
- ► Δεκεμβρίου (186)
- ► Σεπτεμβρίου (472)
- ► Φεβρουαρίου (851)
-
▼
Ιανουαρίου
(788)
-
▼
Ιαν 19
(46)
- IgG4-related Lymphadenopathy: A Comparative Study ...
- Malignant Peritoneal Mesothelioma Arising in Young...
- Histopathologic Characterization of Bladder Periva...
- Postchemotherapy Histiocyte-rich Pseudotumor Mimic...
- DDIT3 Immunohistochemistry Is a Useful Tool for th...
- Clear Cell Adenocarcinoma in Men: A Series of 15 C...
- Phase I Basket Study of Taselisib, an Isoform-Sele...
- A Phase Ib Study of Alpelisib or Buparlisib Combin...
- Sequential Prostate Magnetic Resonance Imaging in ...
- Early Response to First-Line Anti-PD-1 Treatment i...
- OX40 Agonist BMS-986178 Alone or in Combination Wi...
- Neoadjuvant Therapy for Melanoma: A U.S. Food and ...
- Phase Ib Study of Ribociclib plus Fulvestrant and ...
- Phase I Study of Lysine-Specific Demethylase 1 Inh...
- BET Inhibition Enhances the Antileukemic Activity ...
- Blocking IL1 Beta Promotes Tumor Regression and Re...
- Early 3+3 Trial Dose-Escalation Phase I Clinical T...
- Recurrent HNSCC Harbor an Immunosuppressive Tumor ...
- CD19-specific CAR T Cells that Express a PD-1/CD28...
- RNA sequencing and Immunohistochemistry Reveal ZFN...
- PI3K/Akt pathway and Nanog maintain cancer stem ce...
- The role of the glutamine transporter ASCT2 in ant...
- Glutaminolysis is a metabolic route essential for ...
- Efficacy of salvage stereotactic radiotherapy (SRT...
- Variant of SNPs at lncRNA NEAT1 contributes to gas...
- Brachytherapy boost (BT-boost) or stereotactic bod...
- Targeting cancer-promoting inflammation — have ant...
- Hypoxia-inducible miR-196a modulates glioblastoma ...
- PD-1 and PD-L2 expression predict relapse risk and...
- Clinical perspectives of BET inhibition in ovarian...
- Protein arginine methyltransferase 5: a potential ...
- In silico transcriptomic mapping of integrins and ...
- Acetylation-stabilized chloride intracellular chan...
- CHRNA5 belongs to the secondary estrogen signaling...
- The role of capecitabine-based neoadjuvant and adj...
- Tumor volume: a new prognostic factor of oncologic...
- Aglycemic growth enhances carbohydrate metabolism ...
- Comparative analysis of patients with upper urinar...
- Clinical features associated with the efficacy of ...
- Targeting cancer-promoting inflammation — have ant...
- The watch-and-wait strategy versus surgical resect...
- The mutation of BCOR is highly recurrent and oncog...
- Impact of biomarkers and primary tumor location on...
- Biomarker testing and mutation prevalence in metas...
- Appropriateness of trifluridine/tipiracil in the c...
- Nomograms to predict lung metastasis probability a...
-
▼
Ιαν 19
(46)
-
►
2020
(2517)
- ► Δεκεμβρίου (792)
- ► Σεπτεμβρίου (21)
- ► Φεβρουαρίου (28)
-
►
2019
(12076)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (4765)
- ► Ιανουαρίου (5155)
-
►
2018
(3144)
- ► Δεκεμβρίου (3144)
Ετικέτες
Πληροφορίες
Τρίτη 19 Ιανουαρίου 2021
Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa)
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Αναζήτηση αυτού του ιστολογίου
! # Ola via Alexandros G.Sfakianakis on Inoreader
-
Publication date: 1 May 2019 Source: Talanta, Volume 196 Author(s): Ruiqing Long, Te Li, Chaoying Tong, Lihui Wu, Shuyun Shi Abstract...
-
Oral Cancer Rapid Test Kit Market Rugged Expansion Foreseen by 2024 MilTech Oral cancer is one of the largest group of cancers ...
-
Related Articles SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,